Potential Adjunctive Effects of Quercetin–Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study
et al., Pharmaceuticals, doi:10.3390/ph19081202, NCT06974058, Jul 2026
Quercetin for COVID-19
No treatment is 100% effective.
Protocols combine treatments.
Single-arm study of 15 outpatients with mild-to-moderate long COVID showing reductions in symptom burden, fatigue, and pain with quercetin-curcumin treatment. There was no placebo or control group.
Study covers quercetin and curcumin.
Khan et al., 31 Jul 2026, Pakistan, peer-reviewed, 7 authors, trial NCT06974058 (history).
Contact: amjadkhan@lumhs.edu.pk (corresponding author), fazlerabbani@lrh.edu.pk.
Abstract:
Article
Potential Adjunctive Effects of Quercetin-Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study
Amjad Khan 1,2, *, Fazle Rabbani 3, *, Sami Ullah Mumtaz 4 , Roha Javed 5 , Ikram Ujjan 6 , Ayesha Kanwal 3 and Gabriele Conti 7
- 1 Nuffield Division of Clinical Laboratory Sciences (NDCLS), Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
- 2 Department of Biochemistry, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro 76090, Pakistan
- 3 Department of Psychiatry, Lady Reading Hospital (LRH), Peshawar 25000, Pakistan
- 4 Department of Medicine, Narowal Medical College, Narowal 51600, Pakistan
- 5 Department of Diet and Nutritional Sciences, University of Lahore, Lahore 54590, Pakistan
- 6 Department of Pathology, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro 76090, Pakistan
- 7 Human Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
* Correspondence: amjadkhan@lumhs.edu.pk (A.K.); fazlerabbani@lrh.edu.pk (F.R.)
Abstract
Background/Objectives : Long COVID is characterised by persistent symptoms such as fatigue, pain, cognitive impairment, sleep disturbances, and reduced quality of life (QoL) following SARS-CoV-2 infection. Proposed mechanisms include persistent immune activation, chronic inflammation, oxidative stress, endothelial dysfunction, mitochondrial disturbances, and virus-induced cellular senescence. Current management is largely supportive, highlighting the need for complementary strategies targeting these pathways. Natural polyphenols such as quercetin and curcumin possess anti-inflammatory, antioxidant, immunomodulatory, and potential senolytic properties that may modulate multiple pathways implicated in Long COVID. This study aimed to explore the potential complementary effects of oral quercetin-curcumin co-supplementation, administered alongside usual symptomatic management, in adults with persistent Long COVID symptoms. Methods : This single-centre, open-label, single-arm, pragmatic exploratory study enrolled 15 adults with Long COVID in an outpatient real-life clinical practice setting. Participants received a nutraceutical formulation containing quercetin (65 mg) and Curcuma longa extract standardised to provide 42 mg curcumin (Nasafytol ® ), administered as two capsules twice daily for 8 weeks in addition to standard care. The primary endpoint was change in overall symptom burden assessed using the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS). Secondary outcomes included fatigue (Fatigue Severity Scale, FSS), pain (Brief Pain Inventory-Short Form, BPI-SF), cognitive function (Patient-Reported Outcomes Measurement Information System Cognitive Function Short Form 8a, PROMIS-CF-8a), mood (Hospital Anxiety and Depression Scale, HADS), sleep quality (Pittsburgh Sleep Quality Index, PSQI), autonomic symptoms (Composite Autonomic Symptom Score-31, COMPASS-31), and health-related QoL (Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36). Results : After 8 weeks, overall symptom burden significantly decreased (C19-YRS median 50 to 32; q = 0.018). Significant reductions were observed in patient-reported fatigue ( q = 0.006), pain severity and interference ( q = 0.006), and improved physical health-related QoL (SF-36 PCS;
Academic Editor: Pedro Cisternas
Received: 4 July..
DOI record:
{
"DOI": "10.3390/ph19081202",
"ISSN": [
"1424-8247"
],
"URL": "http://dx.doi.org/10.3390/ph19081202",
"abstract": "<jats:p>Background/Objectives: Long COVID is characterised by persistent symptoms such as fatigue, pain, cognitive impairment, sleep disturbances, and reduced quality of life (QoL) following SARS-CoV-2 infection. Proposed mechanisms include persistent immune activation, chronic inflammation, oxidative stress, endothelial dysfunction, mitochondrial disturbances, and virus-induced cellular senescence. Current management is largely supportive, highlighting the need for complementary strategies targeting these pathways. Natural polyphenols such as quercetin and curcumin possess anti-inflammatory, antioxidant, immunomodulatory, and potential senolytic properties that may modulate multiple pathways implicated in Long COVID. This study aimed to explore the potential complementary effects of oral quercetin–curcumin co-supplementation, administered alongside usual symptomatic management, in adults with persistent Long COVID symptoms. Methods: This single-centre, open-label, single-arm, pragmatic exploratory study enrolled 15 adults with Long COVID in an outpatient real-life clinical practice setting. Participants received a nutraceutical formulation containing quercetin (65 mg) and Curcuma longa extract standardised to provide 42 mg curcumin (Nasafytol®), administered as two capsules twice daily for 8 weeks in addition to standard care. The primary endpoint was change in overall symptom burden assessed using the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS). Secondary outcomes included fatigue (Fatigue Severity Scale, FSS), pain (Brief Pain Inventory—Short Form, BPI-SF), cognitive function (Patient-Reported Outcomes Measurement Information System Cognitive Function Short Form 8a, PROMIS-CF-8a), mood (Hospital Anxiety and Depression Scale, HADS), sleep quality (Pittsburgh Sleep Quality Index, PSQI), autonomic symptoms (Composite Autonomic Symptom Score-31, COMPASS-31), and health-related QoL (Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36). Results: After 8 weeks, overall symptom burden significantly decreased (C19-YRS median 50 to 32; q = 0.018). Significant reductions were observed in patient-reported fatigue (q = 0.006), pain severity and interference (q = 0.006), and improved physical health-related QoL (SF-36 PCS; q = 0.025). Numerically favourable changes were also observed in cognitive function, anxiety, sleep quality, and autonomic symptoms, although these did not reach statistical significance. The supplementation was generally well tolerated with no serious adverse events. Conclusions: Quercetin–curcumin co-supplementation was associated with lower patient-reported symptom burden, fatigue, and pain and better physical health-related QoL after 8 weeks of supplementation in adults with Long COVID. These observed findings represent treatment-associated changes within this uncontrolled exploratory study and should be interpreted cautiously. Further evaluation in adequately powered randomised placebo-controlled trials is warranted. Trial registration: ClinicalTrials.gov (ID NCT06974058).</jats:p>",
"alternative-id": [
"ph19081202"
],
"author": [
{
"affiliation": [
{
"name": "Nuffield Division of Clinical Laboratory Sciences (NDCLS), Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK"
},
{
"name": "Department of Biochemistry, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro 76090, Pakistan"
}
],
"family": "Khan",
"given": "Amjad",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Psychiatry, Lady Reading Hospital (LRH), Peshawar 25000, Pakistan"
}
],
"family": "Rabbani",
"given": "Fazle",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Medicine, Narowal Medical College, Narowal 51600, Pakistan"
}
],
"family": "Mumtaz",
"given": "Sami Ullah",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Diet and Nutritional Sciences, University of Lahore, Lahore 54590, Pakistan"
}
],
"family": "Javed",
"given": "Roha",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-9032-4353",
"affiliation": [
{
"name": "Department of Pathology, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro 76090, Pakistan"
}
],
"authenticated-orcid": false,
"family": "Ujjan",
"given": "Ikram",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0009-0004-7484-035X",
"affiliation": [
{
"name": "Department of Psychiatry, Lady Reading Hospital (LRH), Peshawar 25000, Pakistan"
}
],
"authenticated-orcid": false,
"family": "Kanwal",
"given": "Ayesha",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-4623-043X",
"affiliation": [
{
"name": "Human Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy"
}
],
"authenticated-orcid": false,
"family": "Conti",
"given": "Gabriele",
"role": [
{
"role": "author",
"vocabulary": "crossref"
}
],
"sequence": "additional"
}
],
"container-title": "Pharmaceuticals",
"container-title-short": "Pharmaceuticals",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2026,
8,
3
]
],
"date-time": "2026-08-03T01:43:27Z",
"timestamp": 1785721407000
},
"deposited": {
"date-parts": [
[
2026,
8,
5
]
],
"date-time": "2026-08-05T08:22:44Z",
"timestamp": 1785918164000
},
"indexed": {
"date-parts": [
[
2026,
8,
5
]
],
"date-time": "2026-08-05T08:49:53Z",
"timestamp": 1785919793531,
"version": "3.56.0"
},
"is-referenced-by-count": 0,
"issue": "8",
"issued": {
"date-parts": [
[
2026,
7,
31
]
]
},
"journal-issue": {
"issue": "8",
"published-online": {
"date-parts": [
[
2026,
8
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2026,
7,
31
]
],
"date-time": "2026-07-31T00:00:00Z",
"timestamp": 1785456000000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/1424-8247/19/8/1202/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "1202",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2026,
7,
31
]
]
},
"published-online": {
"date-parts": [
[
2026,
7,
31
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"DOI": "10.1093/ofid/ofaf533",
"article-title": "Global Prevalence of Long COVID, its Subtypes and Risk factors: An Updated Systematic Review and Meta-Analysis",
"author": "Hou",
"doi-asserted-by": "crossref",
"first-page": "ofaf533",
"journal-title": "Open Forum Infect. Dis.",
"key": "ref_1",
"volume": "12",
"year": "2025"
},
{
"DOI": "10.1038/s41579-022-00846-2",
"article-title": "Long COVID: Major findings, mechanisms and recommendations",
"author": "Davis",
"doi-asserted-by": "crossref",
"first-page": "133",
"journal-title": "Nat. Rev. Microbiol.",
"key": "ref_2",
"volume": "21",
"year": "2023"
},
{
"DOI": "10.1016/j.cell.2024.07.054",
"article-title": "Mechanisms of long COVID and the path toward therapeutics",
"author": "Peluso",
"doi-asserted-by": "crossref",
"first-page": "5500",
"journal-title": "Cell",
"key": "ref_3",
"volume": "187",
"year": "2024"
},
{
"DOI": "10.1002/jmv.70429",
"article-title": "Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of Symptoms 3 Years Post-SARS-CoV-2 Infection",
"author": "Rahmati",
"doi-asserted-by": "crossref",
"first-page": "e70429",
"journal-title": "J. Med. Virol.",
"key": "ref_4",
"volume": "97",
"year": "2025"
},
{
"DOI": "10.1136/bmj-2024-081318",
"article-title": "Interventions for the management of long COVID (post-COVID condition): Living systematic review",
"author": "Zeraatkar",
"doi-asserted-by": "crossref",
"first-page": "e081318",
"journal-title": "BMJ",
"key": "ref_5",
"volume": "387",
"year": "2024"
},
{
"DOI": "10.1136/bmj.n1648",
"article-title": "Long COVID—Mechanisms, risk factors, and management",
"author": "Crook",
"doi-asserted-by": "crossref",
"first-page": "n1648",
"journal-title": "BMJ",
"key": "ref_6",
"volume": "374",
"year": "2021"
},
{
"DOI": "10.1016/j.pccm.2023.10.003",
"article-title": "Mechanisms of long COVID: An updated review",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "231",
"journal-title": "Chin. Med. J. Pulm. Crit. Care Med.",
"key": "ref_7",
"volume": "1",
"year": "2023"
},
{
"DOI": "10.62210/ClinSciNutr.2024.86",
"article-title": "Investigation of potential effects of quercetin on COVID-19 treatment: A systematic review of randomized controlled trials",
"author": "Bayraktar",
"doi-asserted-by": "crossref",
"first-page": "107",
"journal-title": "Clin. Sci. Nutr.",
"key": "ref_8",
"volume": "6",
"year": "2024"
},
{
"DOI": "10.3389/fimmu.2020.01451",
"doi-asserted-by": "crossref",
"key": "ref_9",
"unstructured": "Colunga Biancatelli, R.M.L., Berrill, M., Catravas, J.D., and Marik, P.E. (2020). Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Front. Immunol., 11."
},
{
"DOI": "10.3389/fphar.2022.1096853",
"doi-asserted-by": "crossref",
"key": "ref_10",
"unstructured": "Di Pierro, F., Khan, A., Iqtadar, S., Mumtaz, S.U., Chaudhry, M.N.A., Bertuccioli, A., Derosa, G., Maffioli, P., Togni, S., and Riva, A. (2022). Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial. Front. Pharmacol., 13."
},
{
"DOI": "10.3390/antiox11050876",
"doi-asserted-by": "crossref",
"key": "ref_11",
"unstructured": "Imran, M., Thabet, H.K., Alaqel, S.I., Alzahrani, A.R., Abida, A., Alshammari, M.K., Kamal, M., Diwan, A., Asdaq, S.M.B., and Alshehri, S. (2022). The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature. Antioxidants, 11."
},
{
"DOI": "10.25259/GJMPBU_78_2023",
"article-title": "Curcumin as a Promising Therapy for COVID-19: A Review",
"author": "Kali",
"doi-asserted-by": "crossref",
"first-page": "2",
"journal-title": "Glob. J. Med. Pharm. Biomed. Update",
"key": "ref_12",
"volume": "19",
"year": "2024"
},
{
"DOI": "10.1038/s41586-021-03995-1",
"article-title": "Virus-induced senescence is a driver and therapeutic target in COVID-19",
"author": "Lee",
"doi-asserted-by": "crossref",
"first-page": "283",
"journal-title": "Nature",
"key": "ref_13",
"volume": "599",
"year": "2021"
},
{
"DOI": "10.1038/s41598-024-61662-7",
"article-title": "Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2",
"author": "Nicoliche",
"doi-asserted-by": "crossref",
"first-page": "10696",
"journal-title": "Sci. Rep.",
"key": "ref_14",
"volume": "14",
"year": "2024"
},
{
"DOI": "10.1186/s12985-024-02299-w",
"article-title": "Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2",
"author": "Roy",
"doi-asserted-by": "crossref",
"first-page": "29",
"journal-title": "Virol. J.",
"key": "ref_15",
"volume": "21",
"year": "2024"
},
{
"DOI": "10.1016/j.ctim.2025.103295",
"article-title": "Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials",
"author": "Sawangjit",
"doi-asserted-by": "crossref",
"first-page": "103295",
"journal-title": "Complement. Ther. Med.",
"key": "ref_16",
"volume": "95",
"year": "2025"
},
{
"DOI": "10.1002/ptr.7724",
"article-title": "Curcumin for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials",
"author": "Shafiee",
"doi-asserted-by": "crossref",
"first-page": "1167",
"journal-title": "Phytother. Res.",
"key": "ref_17",
"volume": "37",
"year": "2023"
},
{
"DOI": "10.3390/nu14020256",
"doi-asserted-by": "crossref",
"key": "ref_18",
"unstructured": "Vahedian-Azimi, A., Abbasifard, M., Rahimi-Bashar, F., Guest, P.C., Majeed, M., Mohammadi, A., Banach, M., Jamialahmadi, T., and Sahebkar, A. (2022). Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials. Nutrients, 14."
},
{
"DOI": "10.1002/ptr.6738",
"article-title": "Potential effects of curcumin in the treatment of COVID-19 infection",
"author": "Zahedipour",
"doi-asserted-by": "crossref",
"first-page": "2911",
"journal-title": "Phytother. Res.",
"key": "ref_19",
"volume": "34",
"year": "2020"
},
{
"DOI": "10.1002/fsn3.3715",
"article-title": "The effect of quercetin supplementation on clinical outcomes in COVID-19 patients: A systematic review and meta-analysis",
"author": "Ziaei",
"doi-asserted-by": "crossref",
"first-page": "7504",
"journal-title": "Food Sci. Nutr.",
"key": "ref_20",
"volume": "11",
"year": "2023"
},
{
"DOI": "10.3389/fphar.2022.898062",
"doi-asserted-by": "crossref",
"key": "ref_21",
"unstructured": "Khan, A., Iqtadar, S., Mumtaz, S.U., Heinrich, M., Pascual-Figal, D.A., Livingstone, S., and Abaidullah, S. (2022). Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results from a Pilot Open-Label, Randomized Controlled Trial. Front. Pharmacol., 13."
},
{
"DOI": "10.3389/fnut.2022.1023997",
"doi-asserted-by": "crossref",
"key": "ref_22",
"unstructured": "Ujjan, I.D., Khan, S., Nigar, R., Ahmed, H., Ahmad, S., and Khan, A. (2022). The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19-Results from a pragmatic randomized clinical trial. Front. Nutr., 9."
},
{
"DOI": "10.3389/fnut.2023.1137407",
"doi-asserted-by": "crossref",
"key": "ref_23",
"unstructured": "Gérain, J., Uebelhoer, M., Costes, B., Herman, J., Pietri, S., Donneau, A.F., Monseur, J., and Henrotin, Y. (2023). NASAFYTOL(®) supplementation in adults hospitalized with COVID-19 infection: Results from an exploratory open-label randomized controlled trial. Front. Nutr., 10."
},
{
"DOI": "10.1080/07853890.2022.2076901",
"article-title": "Pathophysiology and mechanism of long COVID: A comprehensive review",
"author": "Chalon",
"doi-asserted-by": "crossref",
"first-page": "1473",
"journal-title": "Ann. Med.",
"key": "ref_24",
"volume": "54",
"year": "2022"
},
{
"DOI": "10.1007/s00210-024-03369-0",
"article-title": "The analgesic effect of curcumin and nano-curcumin in clinical and preclinical studies: A systematic review and meta-analysis",
"author": "Hajimirzaei",
"doi-asserted-by": "crossref",
"first-page": "393",
"journal-title": "Naunyn Schmiedebergs Arch. Pharmacol.",
"key": "ref_25",
"volume": "398",
"year": "2025"
},
{
"DOI": "10.3390/foods6100092",
"doi-asserted-by": "crossref",
"key": "ref_26",
"unstructured": "Hewlings, S.J., and Kalman, D.S. (2017). Curcumin: A Review of Its Effects on Human Health. Foods, 6."
},
{
"DOI": "10.1093/pm/pnv024",
"article-title": "Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials",
"author": "Sahebkar",
"doi-asserted-by": "crossref",
"first-page": "1192",
"journal-title": "Pain Med.",
"key": "ref_27",
"volume": "17",
"year": "2015"
},
{
"DOI": "10.1016/j.crphar.2025.100217",
"article-title": "Anti-inflammatory potential of quercetin: From chemistry and mechanistic insight to nanoformulations",
"author": "Aggarwal",
"doi-asserted-by": "crossref",
"first-page": "100217",
"journal-title": "Curr. Res. Pharmacol. Drug Discov.",
"key": "ref_28",
"volume": "8",
"year": "2025"
},
{
"key": "ref_29",
"unstructured": "Mushtaq, M., and Anwar, F. (2021). Chapter 15—Quercetin as an antiinflammatory analgesic. A Centum of Valuable Plant Bioactives, Academic Press."
},
{
"DOI": "10.2174/1570159X20666220812122437",
"article-title": "The Emerging Role of Quercetin in the Treatment of Chronic Pain",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "2346",
"journal-title": "Curr. Neuropharmacol.",
"key": "ref_30",
"volume": "20",
"year": "2022"
},
{
"DOI": "10.3390/molecules27010236",
"doi-asserted-by": "crossref",
"key": "ref_31",
"unstructured": "Benameur, T., Giacomucci, G., Panaro, M.A., Ruggiero, M., Trotta, T., Monda, V., Pizzolorusso, I., Lofrumento, D.D., Porro, C., and Messina, G. (2021). New Promising Therapeutic Avenues of Curcumin in Brain Diseases. Molecules, 27."
},
{
"DOI": "10.3390/ijms24076328",
"doi-asserted-by": "crossref",
"key": "ref_32",
"unstructured": "Chiang, M.C., Tsai, T.Y., and Wang, C.J. (2023). The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms. Int. J. Mol. Sci., 24."
},
{
"DOI": "10.1002/jbt.23165",
"article-title": "Neuroprotective effect of quercetin against rotenone-induced neuroinflammation and alterations in mice behavior",
"author": "Jain",
"doi-asserted-by": "crossref",
"first-page": "e23165",
"journal-title": "J. Biochem. Mol. Toxicol.",
"key": "ref_33",
"volume": "36",
"year": "2022"
},
{
"DOI": "10.1007/s11055-024-01640-8",
"article-title": "Exploring the therapeutic potential of quercetin: Mitigating neuroinflammation",
"author": "Kaundal",
"doi-asserted-by": "crossref",
"first-page": "1082",
"journal-title": "Neurosci. Behav. Physiol.",
"key": "ref_34",
"volume": "54",
"year": "2024"
},
{
"DOI": "10.1038/s41598-024-82571-9",
"article-title": "Curcumin reverses cognitive deficits through promoting neurogenesis and synapse plasticity via the upregulation of PSD95 and BDNF in mice",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "1135",
"journal-title": "Sci. Rep.",
"key": "ref_35",
"volume": "15",
"year": "2025"
},
{
"DOI": "10.1016/j.jagp.2017.10.010",
"article-title": "Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial",
"author": "Small",
"doi-asserted-by": "crossref",
"first-page": "266",
"journal-title": "Am. J. Geriatr. Psychiatry",
"key": "ref_36",
"volume": "26",
"year": "2018"
},
{
"DOI": "10.3389/fnut.2025.1549509",
"doi-asserted-by": "crossref",
"key": "ref_37",
"unstructured": "Wang, W., Zhao, R., Liu, B., and Li, K. (2025). The effect of curcumin supplementation on cognitive function: An updated systematic review and meta-analysis. Front. Nutr., 12."
},
{
"DOI": "10.1038/s41598-018-24618-2",
"article-title": "Quercetin attenuates AZT-induced neuroinflammation in the CNS",
"author": "Yang",
"doi-asserted-by": "crossref",
"first-page": "6194",
"journal-title": "Sci. Rep.",
"key": "ref_38",
"volume": "8",
"year": "2018"
},
{
"DOI": "10.3390/ph16071020",
"doi-asserted-by": "crossref",
"key": "ref_39",
"unstructured": "Aghababaei, F., and Hadidi, M. (2023). Recent Advances in Potential Health Benefits of Quercetin. Pharmaceuticals, 16."
},
{
"DOI": "10.4103/0973-7847.194044",
"article-title": "Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid",
"author": "Arulmoli",
"doi-asserted-by": "crossref",
"first-page": "84",
"journal-title": "Pharmacogn. Rev.",
"key": "ref_40",
"volume": "10",
"year": "2016"
},
{
"DOI": "10.1177/21501319241251941",
"article-title": "Determination of COVID-19 Late Disorders as Possible Long-COVID and/or Vaccination Consequences",
"author": "Bavand",
"doi-asserted-by": "crossref",
"first-page": "21501319241251941",
"journal-title": "J. Prim. Care Community Health",
"key": "ref_41",
"volume": "15",
"year": "2024"
},
{
"key": "ref_42",
"unstructured": "(2025, January 01). A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1."
},
{
"DOI": "10.1002/jmv.27415",
"article-title": "The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): Application and psychometric analysis in a post-COVID-19 syndrome cohort",
"author": "Preston",
"doi-asserted-by": "crossref",
"first-page": "1027",
"journal-title": "J. Med. Virol.",
"key": "ref_43",
"volume": "94",
"year": "2022"
},
{
"DOI": "10.1001/archneur.1989.00520460115022",
"article-title": "The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus",
"author": "Krupp",
"doi-asserted-by": "crossref",
"first-page": "1121",
"journal-title": "Arch. Neurol.",
"key": "ref_44",
"volume": "46",
"year": "1989"
},
{
"article-title": "Pain assessment: Global use of the Brief Pain Inventory",
"author": "Cleeland",
"first-page": "129",
"journal-title": "Ann. Acad. Med. Singap.",
"key": "ref_45",
"volume": "23",
"year": "1994"
},
{
"DOI": "10.1111/j.1600-0447.1983.tb09716.x",
"article-title": "The hospital anxiety and depression scale",
"author": "Zigmond",
"doi-asserted-by": "crossref",
"first-page": "361",
"journal-title": "Acta Psychiatr. Scand.",
"key": "ref_46",
"volume": "67",
"year": "1983"
},
{
"DOI": "10.1016/j.jclinepi.2010.04.011",
"article-title": "The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008",
"author": "Cella",
"doi-asserted-by": "crossref",
"first-page": "1179",
"journal-title": "J. Clin. Epidemiol.",
"key": "ref_47",
"volume": "63",
"year": "2010"
},
{
"DOI": "10.1016/0165-1781(89)90047-4",
"article-title": "The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research",
"author": "Buysse",
"doi-asserted-by": "crossref",
"first-page": "193",
"journal-title": "Psychiatry Res.",
"key": "ref_48",
"volume": "28",
"year": "1989"
},
{
"DOI": "10.1016/j.mayocp.2012.10.013",
"article-title": "COMPASS 31: A refined and abbreviated Composite Autonomic Symptom Score",
"author": "Sletten",
"doi-asserted-by": "crossref",
"first-page": "1196",
"journal-title": "Mayo Clin. Proc.",
"key": "ref_49",
"volume": "87",
"year": "2012"
},
{
"DOI": "10.1097/00005650-199206000-00002",
"article-title": "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection",
"author": "Ware",
"doi-asserted-by": "crossref",
"first-page": "473",
"journal-title": "Med. Care",
"key": "ref_50",
"volume": "30",
"year": "1992"
},
{
"article-title": "Preliminary Evidence for the Reliability and Validity of an Abbreviated Profile of Mood States",
"author": "Grove",
"first-page": "93",
"journal-title": "Int. J. Sport Psychol.",
"key": "ref_51",
"volume": "23",
"year": "1992"
},
{
"DOI": "10.1093/arclin/acaa128",
"article-title": "Normative Reference Values, Reliability, and Item-Level Symptom Endorsement for the PROMIS® v2.0 Cognitive Function-Short Forms 4a, 6a and 8a",
"author": "Iverson",
"doi-asserted-by": "crossref",
"first-page": "1341",
"journal-title": "Arch. Clin. Neuropsychol.",
"key": "ref_52",
"volume": "36",
"year": "2021"
},
{
"key": "ref_53",
"unstructured": "Braglia, L. (2026, March 01). lbscorer: Miscellaneous Scoring Functions. R Package Version 0.3. Available online: https://github.com/lbraglia/lbscorer."
},
{
"key": "ref_54",
"unstructured": "R Core Team (2025). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https://www.r-project.org/."
},
{
"DOI": "10.1007/978-3-319-24277-4_9",
"doi-asserted-by": "crossref",
"key": "ref_55",
"unstructured": "Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis, Springer."
},
{
"key": "ref_56",
"unstructured": "Fabbrini, M., and Conti, G. (2026, March 01). microbAIDeR: An Ensemble of Functions for Easier and Quicker Preliminary Microbiome Analysis_. R Package Version 0.3.2. Available online: https://github.com/FabbriniMarco/microbAIDeR."
},
{
"key": "ref_57",
"unstructured": "Oksanen, J., Simpson, G., Blanchet, F., Kindt, R., Legendre, P., Minchin, P., O’Hara, R., Solymos, P., Stevens, M., and Szoecs, E. (2026, March 01). vegan: Community Ecology Package. R Package Version 2.7-5. Available online: https://CRAN.R-project.org/package=vegan."
}
],
"reference-count": 57,
"references-count": 57,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/1424-8247/19/8/1202"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Potential Adjunctive Effects of Quercetin–Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study",
"type": "journal-article",
"update-policy": "https://doi.org/10.3390/mdpi_crossmark_policy",
"volume": "19"
}
